Stephen Taub

Latest Articles

biopharma

Biopharma Hedge Funds Stumble as Last Year’s Rally Fades

Stephen Taub February 12, 2026

light street

Light Street’s New Long Game

Stephen Taub February 11, 2026

divergent paths

Viking Hybrid Fund Gains in the Fourth Quarter as Private Investment Strategy Slips

Stephen Taub February 10, 2026

shakeup

Third Point Overhauls Its Top Holdings in an Unusual Shake-Up

Stephen Taub February 9, 2026

big jump

Haidar Kicks Off the Year With a Big Jump as Discovery Builds on Its Multi‑Year Tear

Stephen Taub February 5, 2026

silicon chips

‘AI Supercycle Is Here to Stay’: Light Street Posts Strong January Returns as It Revamps Tech Strategy

Stephen Taub February 4, 2026

unicorn

A Unicorn IPO Wave Could Deliver Windfalls for Hedge Funds

Stephen Taub February 3, 2026

bear at a party

Bearish but Booming, David Einhorn’s Greenlight Starts 2026 With a Win

Stephen Taub February 2, 2026

test tube

With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma

Stephen Taub January 29, 2026

plane

The Tiger Grandcub Who Outsmarted the AI Frenzy

Stephen Taub January 28, 2026

streak

How Hiddenite, a Young Long‑Short Fund, Delivered a Second Straight Triple‑Digit Year

Stephen Taub January 27, 2026

whispering

The Lowdown on High Ground’s Best Year

Stephen Taub January 26, 2026

streak

Robert Citrone’s Discovery Capital Scores a Three‑Year Run of Outsized Returns

Stephen Taub January 22, 2026

green background

Greenlight to Close to New Capital

Stephen Taub January 20, 2026

power

How Electron Is Rewiring Its Portfolio This Year After a Muted Finish to 2025

Stephen Taub January 20, 2026

Splinters

CTA Performance Splinters As a Late Surge Lifts Some, But Not All

Stephen Taub January 15, 2026

rollercoaster

From Deep Losses to Remarkable Gains: Biopharma’s Wildest Year in Recent Memory

Stephen Taub January 14, 2026

geopolitical

Caxton and Graham Post Solid Gains in a Strong Year for Macro Funds

Stephen Taub January 13, 2026

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2026 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.15.08 build:2026-02-17 Login